AVAI AVAI BIO, INC.
Services-Computer Processing & Data Preparation · OTC · SEC CIK 1740797 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-3,582.8%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-239.1%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets405.2%
Debt / equity—
Current ratio0.04x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.55x
Accruals ratio-107.6%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-31 | FY20252025-03-31 | FY20242024-03-31 | FY20222023-03-31 | FY2022*2022-03-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | — | — | $276,324 | $499,718 |
| Cost of revenue | — | — | — | $276,324 | $710,512 |
| Gross profit | — | — | — | -$40,453 | -$210,794 |
| R&D expense | $15,000 | — | — | — | — |
| SG&A expense | $792,265 | $762,478 | $1.42M | $234,907 | $449,361 |
| Operating income | -$1.75M | -$1.14M | -$2.13M | -$348,933 | $126,521 |
| Net income | -$1.75M | -$1.14M | -$2.13M | -$348,933 | -$126,521 |
| EBITDA | -$1.72M | -$1.07M | -$2.05M | -$325,516 | — |
| EPS (basic) | -0.01 | -0.01 | -0.02 | 0.00 | 0.00 |
| EPS (diluted) | — | — | — | — | — |
| Banking | |||||
| Net interest income | — | — | — | $276,324 | $921,306 |
| Loans, net | — | — | — | — | $167,558 |
| Balance sheet | |||||
| Cash & equivalents | $23,145 | $81,053 | $281 | $107,472 | $33,289 |
| Receivables | — | — | — | — | $3,765 |
| Current assets | $89,340 | $93,133 | $116,082 | $107,575 | $330,872 |
| PP&E, net | $1,500 | — | $1,500 | $1,500 | $1,500 |
| Intangibles | $105,542 | $131,612 | $205,932 | $133,760 | — |
| Total assets | $572,696 | $224,745 | $322,014 | $241,460 | $454,664 |
| Current liabilities | $3.39M | $1.79M | $1.79M | $874,719 | $860,225 |
| Short-term debt | $24,918 | $30,000 | — | $99,000 | $99,000 |
| Total liabilities | $3.39M | $1.79M | $1.79M | $874,719 | $860,225 |
| Shareholders' equity | -$2.82M | -$1.56M | -$1.47M | -$633,259 | -$405,561 |
| Shares outstanding | 153.21M | 137.36M | 117.17M | 38.50M | 26.32M |
| Cash flow statement | |||||
| Operating cash flow | -$1.01M | -$1.16M | -$1.32M | -$54,457 | $535,008 |
| Investing cash flow | — | — | -$149,000 | -$33,510 | -$33,719 |
| Financing cash flow | $951,936 | $1.24M | $1.36M | $162,150 | $474,214 |
| Depreciation & amortization | $26,070 | $74,320 | $76,953 | $23,417 | — |
Free plan shows the latest 5 periods; Pro shows all 8 🔒
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.